V

Valion Bio Inc.
D

VBIO

0.52000
USD
-0.02
(-3.88%)
مغلق
حجم التداول
0
الربح لكل سهم
-24
العائد الربحي
-
P/E
-0
حجم السوق
1,664,428
المقالات
المزيد

العنوان: Valion Bio Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.